Indonesia’s Adjuvant industry | Opportunities | Upcoming Projects|Investment opportunities |Forecast to 2020
Market Entry - Adjuvant Industry in Indonesia: Analysis of Growth, Trends and Progress (2016 - 2021)

PUBLISHED

DEC 2017

Market Entry - Adjuvant Industry in Indonesia: Analysis of Growth, Trends and Progress (2016 - 2021)

Purchase Report

About the Market

Increase in the prevalence of cancer, growing reimbursement initiatives by governments and insurance companies covering treatment for cancer, with growth in preference for the future prevention of cancer are some of the major drivers of this market. The overall market for oncology adjuvants is classified on the basis of applications such as chemotherapy, radiotherapy, immunotherapy etc. By diseases which are treated through adjuvants, this market is classified into breast cancer, colorectal cancer, sarcoma, Hodgkin’s lymphoma, glioblastoma, lung cancer, prostate cancer, and ovarian cancer. North America, followed by Europe dominates the global market for breast cancer treatment, due to increasing incidence of cancer cases and technological advancement in the region. Some of the market players in this industry include pharmaceutical manufacturers such as Amgen Inc., Eli Lilly Co., BMS, Biogen, AstraZeneca PLC, Sanofi, and Pfizer Inc.

About the Geography

Indonesia, with 252 million inhabitants, is the world’s fourth most populous country with a large middle-class population. It is the 16th largest economy in the world and is projected to be the seventh largest by 2030.

Incentives to investment are accessible to all investors, whether national or foreign. In 2006, the government improved the investment climate by a reduction in time required for the creation of a company, rationalization, and improvement of customs procedures and regulations. Privatization program affecting sectors like transport and finance is regularly updated. The country allows majority holding interest in the capital of Indonesian companies, except in certain sensitive sectors. The state also provides incentives to companies, which choose to set up in one of the seven customs areas. 

The constraints to starting a business in Indonesia include the formalities to be carried out and the inefficiency of the local authorities. The authorities here are still viewed as being generally corrupted as compared to other Southeast Asian nations. However, Indonesia still comprises of almost 50% of the GDP of ASEAN countries and with its growing middle class, huge consumer base and abundance of natural resources, it has become an attractive destination for investors.

 

Component Name

Unit

From Site

GDP

USD billion

862

GDP Annual Growth Rate

%

5.18

GDP Per Capita

USD

3834

Unemployment Rate

%

5.5

Inflation Rate

%

3.07

Consumer Price Index (CPI)

Index Points

125

Interest Rate

%

5

Loans to Private Sector

USD million/billion

286.2480 billion

Balance of Trade

USD million/billion

1217 million

Business Confidence

(No Units)

110

Manufacturing PMI

Index Points

50.9

Ease of Doing Business

(No Units)

109

Competitiveness Rank

(No Units)

41

Corruption Rank

(No Units)

88

Consumer Confidence

(No Units)

110

Consumer Spending

USD million/billion

96.59851 billion

Corporate Tax Rate

%

25

Sales Tax Rate

%

10

 

The Market Entry Series

Exploring global markets is now recognized as the shortest way to ensure high time to efficiency conversion, when trying to expand revenues past domestic markets, for firms both large and small. Our market entry series, priced suitably low contains the essentials of all the parameters (Refer: Table of Contents) you must be apprised of before you can have a well informed contemplation of a business opportunity in your choice of industry, in your choice of geography.

1. Introduction

                1.1 Scope of the Report

                1.2 Regional Analysis

                                1.2.1 PESTLE Analysis

                                1.2.2 Analysis of Ease of Doing Business

2. Market Dynamics

                2.1 Drivers

                2.2 Restraints

                2.3 Opportunities

3. Market Demand Analysis

                3.1 Socio-Economic Segmentation

                3.2 Demographic Strengths & Weaknesses

                3.3 Spending Patterns

                3.4 Target Market Identification

4. Market Size of Adjuvant Industry (USD millions)

                4.1 By Types of Inorganic Compounds

                4.2 By Bacterial Products

5. Market Entry

                5.1 Market Entry: The Strategy

                                5.1.1 Types of Entry Modes, by Market Entry Objectives

                                5.1.2 Competition Analysis

                                                5.1.2.1 Market Share

                                                5.1.2.2 Strategies Adopted, Recent Events 

                                5.1.3 Pricing Strategy

                                5.1.4 Supply Chain Analysis

                                                5.1.4.1 Trade (Import-Export Analysis)

                                                5.1.4.2 Distribution Network & Retail Analysis

                5.2 Market Entry: The Administration

                                5.2.1 How to Register a Company (Flowchart)

                                5.2.2 Registration Processes 

                                                5.2.2.1 Ministries Involved

                                                5.2.2.2 Criteria and Conditions

                                5.2.3 List of Forms & Documents

                                5.2.4 Product Control Guidelines specified by the Government

6. Sources

7. Disclaimer

Purchase Report

Our Clients Include View All

Looking to Customize Report?